BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25205514)

  • 1. Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms.
    Kushekhar K; van den Berg A; Nolte I; Hepkema B; Visser L; Diepstra A
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2737-47. PubMed ID: 25205514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
    Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
    Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
    Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadié M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini RM; Adami HO; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjønneland A; Melin B; Canzian F; Khaw KT; Travis RC; Peeters PH; González CA; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjosé S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
    J Natl Cancer Inst; 2012 Feb; 104(3):240-53. PubMed ID: 22286212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
    Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
    Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.
    Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadié M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjosé S; Lathrop M; Melbye M; Brennan P; Diepstra A; van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1838-43. PubMed ID: 26404960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
    Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
    Blood; 2011 Nov; 118(19):5211-7. PubMed ID: 21921049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
    Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
    PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.
    Jones K; Wockner L; Thornton A; Gottlieb D; Ritchie DS; Seymour JF; Kumarasinghe G; Gandhi MK
    Transpl Immunol; 2015 Mar; 32(2):126-30. PubMed ID: 25731678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
    Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
    Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA associations in classical Hodgkin lymphoma: EBV status matters.
    Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
    PLoS One; 2012; 7(7):e39986. PubMed ID: 22808081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China.
    Huang X; Hepkema B; Nolte I; Kushekhar K; Jongsma T; Veenstra R; Poppema S; Gao Z; Visser L; Diepstra A; van den Berg A
    PLoS One; 2012; 7(2):e31865. PubMed ID: 22355400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
    Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
    Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
    Barros MH; Hassan R; Niedobitek G
    Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
    Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
    Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
    Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
    Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotypic abnormalities associated with Epstein-Barr virus status in classical Hodgkin lymphoma.
    Montgomery ND; Coward WB; Johnson S; Yuan J; Gulley ML; Mathews SP; Kaiser-Rogers K; Rao KW; Sanger WG; Sanmann JN; Fedoriw Y
    Cancer Genet; 2016 Sep; 209(9):408-416. PubMed ID: 27751359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.